GT199700043A - Derivados del indazol sustituidos y compuestos relacionados - Google Patents
Derivados del indazol sustituidos y compuestos relacionadosInfo
- Publication number
- GT199700043A GT199700043A GT199700043A GT199700043A GT199700043A GT 199700043 A GT199700043 A GT 199700043A GT 199700043 A GT199700043 A GT 199700043A GT 199700043 A GT199700043 A GT 199700043A GT 199700043 A GT199700043 A GT 199700043A
- Authority
- GT
- Guatemala
- Prior art keywords
- tnf
- related compounds
- production
- substituted indazol
- derivatives
- Prior art date
Links
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 3
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010012434 Dermatitis allergic Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A LA SERIE DE ANALOGOS DEL INDAZOL, NUEVOS QUE SON INHIBIDORES SELECTIVOS DE LA FOSFODIESTERESA (PDE) TIPO IV Y DE LA PRODUCCION DEL FACTOR DE NECROSIS TUMORAL (TNF) Y COMO TALES SON UTILES EN EL TRATAMIENTO DEL ASMA, ARTRITIS, BRONQUITIS, ENFERMEDAD OBSTRUCTIVA CRONICA DE LAS VIAS RESPIRATORIAS, RINITIS ALERGICA, DERMATITIS Y OTRAS ENFERMEDADES INFLAMATORIAS, SIDA, CHOQUE SEPTICO Y OTRAS ENFERMEDADES QUE IMPLICAN LA PRODUCCION DEL TNF. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA I, EN LA QUE R, R1 Y R2, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1686196P | 1996-05-03 | 1996-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199700043A true GT199700043A (es) | 1998-10-02 |
Family
ID=21779401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199700043A GT199700043A (es) | 1996-05-03 | 1997-04-10 | Derivados del indazol sustituidos y compuestos relacionados |
Country Status (42)
| Country | Link |
|---|---|
| US (2) | US6211222B1 (es) |
| EP (1) | EP0912521B1 (es) |
| JP (1) | JP3148254B2 (es) |
| KR (1) | KR100339935B1 (es) |
| CN (2) | CN1112359C (es) |
| AP (4) | AP1147A (es) |
| AR (1) | AR006906A1 (es) |
| AT (1) | ATE292626T1 (es) |
| AU (1) | AU725576B2 (es) |
| BG (1) | BG64211B1 (es) |
| BR (1) | BR9709051A (es) |
| CA (2) | CA2252982C (es) |
| CO (1) | CO4650038A1 (es) |
| CZ (1) | CZ292825B6 (es) |
| DE (1) | DE69732966T2 (es) |
| DZ (1) | DZ2217A1 (es) |
| EA (1) | EA002272B1 (es) |
| ES (1) | ES2238079T3 (es) |
| GT (1) | GT199700043A (es) |
| HK (1) | HK1019443A1 (es) |
| HN (1) | HN1997000046A (es) |
| HR (1) | HRP970227B1 (es) |
| HU (1) | HUP9902459A3 (es) |
| ID (1) | ID16856A (es) |
| IL (2) | IL126547A (es) |
| IS (1) | IS4871A (es) |
| MA (1) | MA24158A1 (es) |
| MY (1) | MY132499A (es) |
| NO (1) | NO312959B1 (es) |
| NZ (1) | NZ332240A (es) |
| OA (1) | OA10904A (es) |
| PE (1) | PE64598A1 (es) |
| PL (1) | PL329836A1 (es) |
| SK (1) | SK148298A3 (es) |
| TN (1) | TNSN97070A1 (es) |
| TR (1) | TR199802202T2 (es) |
| TW (1) | TW449585B (es) |
| UA (1) | UA65536C2 (es) |
| UY (1) | UY24532A1 (es) |
| WO (1) | WO1997042174A1 (es) |
| YU (1) | YU16397A (es) |
| ZA (1) | ZA973804B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1147A (en) * | 1996-05-03 | 2003-02-25 | Pfizer | Substituted indazole derivatives and related compounds. |
| US6005118A (en) * | 1996-05-03 | 1999-12-21 | Caron; Stephane | Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors |
| CA2258728C (en) * | 1996-06-19 | 2011-09-27 | Rhone Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| US6011159A (en) * | 1997-05-08 | 2000-01-04 | Pfizer Inc | Processes and intermediates for preparing substituted indazole derivatives |
| CN1281441A (zh) * | 1997-11-04 | 2001-01-24 | 辉瑞产品公司 | 以在pde4抑制剂中的儿茶酚的吲唑生物等排物置换为基础的治疗活性化合物 |
| WO1999023077A1 (en) * | 1997-11-04 | 1999-05-14 | Pfizer Products Inc. | Indazole bioisostere replacement of catechol in therapeutically active compounds |
| IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
| IL132407A0 (en) * | 1998-10-21 | 2001-03-19 | Pfizer Prod Inc | Method for treating congestive heart failure |
| JP2000198734A (ja) * | 1998-12-30 | 2000-07-18 | Pfizer Inc | 胃運動性減弱および関連疾患の治療のための運動性増強薬 |
| US6362213B1 (en) | 1999-12-23 | 2002-03-26 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
| EP1244649B1 (en) * | 1999-12-23 | 2005-03-02 | Icos Corporation | Cyclic amp-specific phosphodiesterase inhibitors |
| US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| US7211594B2 (en) * | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| US6953774B2 (en) | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
| EA011213B1 (ru) | 2001-12-14 | 2009-02-27 | Лаборатуар Сероно Са | Способ индуцирования овуляции с использованием ингибитора изоформы фосфодиэстеразы 4 (pde4) |
| US20040034084A1 (en) * | 2002-05-24 | 2004-02-19 | Celgene Corporation | Methods for using JNK inhibitors for treating or preventing disease-related wasting |
| US7196082B2 (en) * | 2002-11-08 | 2007-03-27 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
| US20050019366A1 (en) * | 2002-12-31 | 2005-01-27 | Zeldis Jerome B. | Drug-coated stents and methods of use therefor |
| DE10318610A1 (de) | 2003-04-24 | 2004-11-11 | Elbion Ag | 7-Azaindole und deren Verwendung als Therapeutika |
| US7601847B2 (en) | 2004-10-26 | 2009-10-13 | Wyeth | Preparation and purification of 4-(indazol-3-yl)phenols |
| US20070004777A1 (en) * | 2005-03-23 | 2007-01-04 | Bhagwat Shripad S | Methods for treating or preventing acute myelogenous leukemia |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US8277809B2 (en) * | 2006-04-21 | 2012-10-02 | Centocor, Inc. | CXCL13 antagonists and their use for the treatment of inflammatory diseases |
| EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| IL274444B2 (en) | 2017-11-06 | 2024-06-01 | Rapt Therapeutics Inc | Chemokine receptor modulators for the treatment of Epstein-Barr virus-positive cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3994890A (en) * | 1974-01-31 | 1976-11-30 | Chugai Seiyaku Kabushiki Kaisha | 1-Aminoalkyl, 3-phenyl indazoles |
| JPS5654437A (en) * | 1979-10-09 | 1981-05-14 | Konishiroku Photo Ind Co Ltd | Direct positive image forming method |
| GB8707051D0 (en) * | 1986-04-15 | 1987-04-29 | Ici America Inc | Heterocyclic carboxamides |
| JP2525286B2 (ja) * | 1990-11-26 | 1996-08-14 | 日本原子力研究所 | 超耐熱性炭化ケイ素繊維の製造方法 |
| TW223004B (es) * | 1991-11-25 | 1994-05-01 | Sumitomo Chemical Co | |
| WO1993018008A1 (en) * | 1992-03-09 | 1993-09-16 | Zeneca Limited | Novel arylindazoles and their use as herbicides |
| US5444038A (en) * | 1992-03-09 | 1995-08-22 | Zeneca Limited | Arylindazoles and their use as herbicides |
| MX9301943A (es) * | 1992-04-02 | 1994-08-31 | Smithkline Beecham Corp | Compuestos. |
| US5554620A (en) * | 1993-09-14 | 1996-09-10 | Sterling Winthrop Inc. | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof |
| US5440038A (en) * | 1993-12-07 | 1995-08-08 | Miles Inc. | Process for the purification of substituted 4-amino-1,2,4-triazine-5-ones |
| CZ120097A3 (cs) * | 1994-10-20 | 1998-01-14 | Pfizer Inc. | Bicyklické tetrahydropyrazolopyridiny a farmaceutické prostředky na jejich bázi |
| JPH10509469A (ja) * | 1994-10-21 | 1998-09-14 | エリシャ・テクノロジーズ・カンパニー・エルエルシー | 金属製造物のための腐食抵抗緩衝系 |
| AP1147A (en) * | 1996-05-03 | 2003-02-25 | Pfizer | Substituted indazole derivatives and related compounds. |
| US6011159A (en) * | 1997-05-08 | 2000-01-04 | Pfizer Inc | Processes and intermediates for preparing substituted indazole derivatives |
-
1996
- 1996-05-03 AP APAP/P/2001/002294A patent/AP1147A/en active
- 1996-05-03 AP AP2001002304A patent/AP2001002304A0/xx unknown
-
1997
- 1997-01-04 UA UA98105434A patent/UA65536C2/uk unknown
- 1997-04-01 KR KR1019980708867A patent/KR100339935B1/ko not_active IP Right Cessation
- 1997-04-01 PL PL97329836A patent/PL329836A1/xx unknown
- 1997-04-01 IL IL12654797A patent/IL126547A/xx not_active IP Right Cessation
- 1997-04-01 CA CA002252982A patent/CA2252982C/en not_active Expired - Fee Related
- 1997-04-01 AP APAP/P/2001/002304A patent/AP0102304A0/en unknown
- 1997-04-01 EA EA199800882A patent/EA002272B1/ru not_active IP Right Cessation
- 1997-04-01 CN CN97194356A patent/CN1112359C/zh not_active Expired - Fee Related
- 1997-04-01 CZ CZ19983492A patent/CZ292825B6/cs not_active IP Right Cessation
- 1997-04-01 AT AT97907247T patent/ATE292626T1/de not_active IP Right Cessation
- 1997-04-01 EP EP97907247A patent/EP0912521B1/en not_active Expired - Lifetime
- 1997-04-01 BR BR9709051A patent/BR9709051A/pt active Search and Examination
- 1997-04-01 NZ NZ332240A patent/NZ332240A/xx unknown
- 1997-04-01 DE DE69732966T patent/DE69732966T2/de not_active Expired - Fee Related
- 1997-04-01 TR TR1998/02202T patent/TR199802202T2/xx unknown
- 1997-04-01 ES ES97907247T patent/ES2238079T3/es not_active Expired - Lifetime
- 1997-04-01 HU HU9902459A patent/HUP9902459A3/hu unknown
- 1997-04-01 JP JP53967097A patent/JP3148254B2/ja not_active Expired - Fee Related
- 1997-04-01 CA CA002389918A patent/CA2389918A1/en not_active Abandoned
- 1997-04-01 AU AU19373/97A patent/AU725576B2/en not_active Ceased
- 1997-04-01 WO PCT/IB1997/000323 patent/WO1997042174A1/en active IP Right Grant
- 1997-04-01 TW TW086104176A patent/TW449585B/zh active
- 1997-04-01 SK SK1482-98A patent/SK148298A3/sk unknown
- 1997-04-01 IL IL15208397A patent/IL152083A0/xx unknown
- 1997-04-04 HN HN1997000046A patent/HN1997000046A/es unknown
- 1997-04-10 GT GT199700043A patent/GT199700043A/es unknown
- 1997-04-28 UY UY24532A patent/UY24532A1/es not_active IP Right Cessation
- 1997-04-29 AR ARP970101769A patent/AR006906A1/es not_active Application Discontinuation
- 1997-04-29 YU YU16397A patent/YU16397A/sh unknown
- 1997-04-30 AP APAP/P/1997/000975A patent/AP1146A/en active
- 1997-04-30 DZ DZ970064A patent/DZ2217A1/fr active
- 1997-04-30 TN TNTNSN97070A patent/TNSN97070A1/fr unknown
- 1997-04-30 PE PE1997000330A patent/PE64598A1/es not_active Application Discontinuation
- 1997-04-30 MA MA24577A patent/MA24158A1/fr unknown
- 1997-05-02 ZA ZA973804A patent/ZA973804B/xx unknown
- 1997-05-02 ID IDP971466A patent/ID16856A/id unknown
- 1997-05-02 HR HR970227A patent/HRP970227B1/xx not_active IP Right Cessation
- 1997-05-02 MY MYPI97001923A patent/MY132499A/en unknown
- 1997-05-05 CO CO97023872A patent/CO4650038A1/es unknown
- 1997-11-04 US US08/963,904 patent/US6211222B1/en not_active Expired - Fee Related
-
1998
- 1998-10-16 IS IS4871A patent/IS4871A/is unknown
- 1998-10-23 OA OA9800201A patent/OA10904A/en unknown
- 1998-11-02 NO NO19985095A patent/NO312959B1/no not_active IP Right Cessation
- 1998-11-23 BG BG102946A patent/BG64211B1/bg unknown
-
1999
- 1999-09-27 US US09/406,220 patent/US6127398A/en not_active Expired - Fee Related
- 1999-10-08 HK HK99104439A patent/HK1019443A1/xx not_active IP Right Cessation
-
2002
- 2002-11-08 CN CN02149950A patent/CN1422849A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT199700043A (es) | Derivados del indazol sustituidos y compuestos relacionados | |
| GT199700102A (es) | Derivados de indazol. | |
| GT199700075A (es) | Analogos de indazol sustituido | |
| ES2192192T3 (es) | Dieteres de catecol como inhibidores selectivos de pde iv. | |
| HN1999000130A (es) | 1-aril-3-arilmetil-1,8-naftiridin-4(1h)-onas. | |
| GT199800058A (es) | Derivados de nicotinamida. | |
| DE60210805D1 (de) | Substituierte indolizinähnliche verbindungen und ihre verwendung | |
| MX9405132A (es) | Tetrahidro pirazolopiridinas biciclicas. | |
| EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
| ECSP067057A (es) | Nuevos derivados de piridazin-3(2h)-ona | |
| UY27199A1 (es) | Nuevos compuestos antiinflamatorios de triazolopiridinas | |
| DOP2013000315A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a | |
| UY32006A (es) | Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
| AR041252A1 (es) | Compuestos de fenil - aza- benzimidazol para modular la ige e inhibir la proliferacion celular, uso en asma, alergia y cancer | |
| CY1113654T1 (el) | Αρυλ ουριες ως αναστολεις κινασων | |
| CO4180606A1 (es) | Compuestos de isoxazolina como agentes antiinflamatorios | |
| GT200600297A (es) | Nuevos anticuerpos anti-madcam | |
| GT200800198A (es) | Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide del tipo 1. | |
| GT200100014A (es) | Compuestos de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo. | |
| CR6630A (es) | Compuestos de indazol, compuestos farmacologicos y metodos para la intervencion o inhibicion de la proliferacion celular | |
| RU2008150621A (ru) | Лечение депрессивных расстройств | |
| UY28720A1 (es) | Uso de pteridinas sustituidas para el tratamiento de enfermedades de la vías respiratorias | |
| ES2172583T3 (es) | 5,6-dihidro-9h-pirazol(3,4-c)-1,2,4-triazol(4,3-alfa)piridinas triciclicas. | |
| TW200740808A (en) | Inhibiteurs de proteines kinases | |
| DE60141636D1 (de) | Phospholipidderivate von valproinsäure und ihre kombinationen |